| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.05 |